Quriegen
QurieGen (est. April 2022) aspires to revolutionize drug discovery. This biotech startup leverages a proprietary method of mapping cellular responses to drug stimuli. Uniquely, this disruptive technology reveals the full picture of the signaling pathways, replacing many different, mutually incompatible analytical tools that at best provide an incomplete picture of the cell response to drug perturbations. The QurieGen R&D team will build a unique AI platform to predict cellular responses to drug candidate molecules, enabling data-driven discovery. Currently, we are raising seed investment to accelerate our operations. Please contact us if you are interested in investing in QurieGen.
7-day free trial · no credit card
Verified contacts
9
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 9 verified contacts at Quriegen
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
9 contacts with verified email or phone · masked until revealed.
- MN
Mahira Nabizada
Business Development Manager · Sales & Business Development
EmailPhone - KZ
Klaske Zwaan
Research Assistant · Research & Development
EmailPhone - MJ
MacIej Jarzab
Investor, Chief Operating Officer · Other
EmailPhone
Showing 3 of 9 verified contacts
Top roles at Quriegen
8 distinct titles indexed · top 8 shown.
- 1bd global
- 1business development manager
- 1chief executive officer
- 1innovation and project specialist
- 1investor, chief operating officer
- 1research assistant
- 1senior biologist
- 1senior scientist
Sign up to unlock all 9 contacts at Quriegen
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 9 verified contacts at Quriegen
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.